What is Docetaxel-trastuzumab-pertuzumab (DHP)?

Category: Prescription Drugs

false

See also: Docetaxel Pertuzumab Trastuzumab

Docetaxel-trastuzumab-pertuzumab, also known as DHP, is a regimen that may be used for the treatment of breast cancer. It contains the anticancer agents docetaxel (Taxotere®), trastuzumab (Herceptin®), and pertuzumab (Perjeta®).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
2
Mild
0
None
0

Commonly reported side effects and conditions associated with Docetaxel-trastuzumab-pertuzumab (DHP)

Side effect Patients
Fatigue 1
Pain 1

Dosages

Based on patients currently taking Docetaxel-trastuzumab-pertuzumab (DHP)

Dosage Patients
every 3 weeks 1

Duration

Currently taking Docetaxel-trastuzumab-pertuzumab (DHP)

Duration Patients
6 months - 1 year 1
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 0
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 1
Last updated:
There are no evaluations for Docetaxel-trastuzumab-pertuzumab (DHP).